SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-000073
Filing Date
2024-01-02
Accepted
2024-01-02 09:26:25
Documents
4
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea190898-6k_scinaiimmun.htm 6-K 28970
2 FORM OF INDUCEMENT LETTERS ea190898ex10-1_scinaiimmun.htm EX-10.1 52745
3 FORM OF NEW WARRANTS ea190898ex10-2_scinaiimmun.htm EX-10.2 110781
4 FORM OF PLACEMENT AGENT WARRANTS ea190898ex10-3_scinaiimmun.htm EX-10.3 108996
  Complete submission text file 0001213900-24-000073.txt   302742
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 24500600
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)